Your browser doesn't support javascript.
loading
Strategies for improving fengycin production: a review.
Yin, Ying; Wang, Xin; Zhang, Pengsheng; Wang, Pan; Wen, Jianping.
Afiliação
  • Yin Y; Key Laboratory of Systems Bioengineering (Ministry of Education), Tianjin University, Tianjin, 300072, P. R. China.
  • Wang X; SynBio Research Platform, Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), School of Chemical Engineering and Technology, Tianjin University, Tianjin, China.
  • Zhang P; Frontiers Science Center for Synthetic Biology (Ministry of Education), Tianjin University, Tianjin, China.
  • Wang P; Coll Biol & Pharmaceut Sci, China Three Gorges Univ, Yichang, 443002, P. R. China.
  • Wen J; Key Laboratory of Systems Bioengineering (Ministry of Education), Tianjin University, Tianjin, 300072, P. R. China.
Microb Cell Fact ; 23(1): 144, 2024 May 22.
Article em En | MEDLINE | ID: mdl-38773450
ABSTRACT
Fengycin is an important member of the lipopeptide family with a wide range of applications in the agricultural, food, medical and cosmetic industries. However, its commercial application is severely hindered by low productivity and high cost. Therefore, numerous studies have been devoted to improving the production of fengycin. We summarize these studies in this review with the aim of providing a reference and guidance for future researchers. This review begins with an overview of the synthesis mechanism of fengycin via the non-ribosomal peptide synthetases (NRPS), and then delves into the strategies for improving the fengycin production in recent years. These strategies mainly include fermentation optimization and metabolic engineering, and the metabolic engineering encompasses enhancement of precursor supply, application of regulatory factors, promoter engineering, and application of genome-engineering (genome shuffling and genome-scale metabolic network model). Finally, we conclude this review with a prospect of fengycin production.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lipopeptídeos / Engenharia Metabólica Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lipopeptídeos / Engenharia Metabólica Idioma: En Ano de publicação: 2024 Tipo de documento: Article